JamesDSanchezMD

Summary

• Dr. James Sanchez is an Oncologist based in Las Vegas, NV, with expertise in various areas including amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma. His extensive education includes fellowships in Hematology and Medical Oncology from the University of Alabama Medical Center and the University of Michigan Health System, a residency in Internal Medicine at the University of Michigan Health System, and medical degree from the University of Utah School of Medicine. He has contributed to medical research through publications like 'A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer' and 'A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinoma'. He has also been involved in clinical trials studying Abemaciclib in treated KRAS Mutated Lung Cancer patients and Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma cases.